Legend Biotech Appoints Finance Veteran Gareth Kung to Board, Audit Committee Chair

summarizeSummary

Legend Biotech has appointed Gareth Kung, a seasoned finance executive with extensive CFO experience, to its Board of Directors, where he will also chair the Audit Committee.

check_boxKey Events

• New Director Appointed

  Gareth Kung has been appointed to Legend Biotech's Board of Directors, effective February 2, 2026, serving as a Class II director until the 2028 annual general meeting.

• Audit Committee Chair

  Mr. Kung will replace Tomas Heyman as the chair of the Board's Audit Committee, effective February 2, 2026.

• Extensive Financial Expertise

  Mr. Kung brings significant financial leadership experience, having served as CFO for several companies and holding certifications as a CPA, Chartered Accountant, and CFA.

• Compensation Details

  Mr. Kung will receive a restricted share unit award equivalent to $270,000, vesting over three years, along with annual cash retainers totaling $100,000 for his board and committee chair roles.

auto_awesomeAnalysis

This appointment strengthens Legend Biotech's corporate governance and financial oversight capabilities. Mr. Kung's background as a Certified Public Accountant and Chartered Financial Analyst, coupled with his extensive experience as a Chief Financial Officer in various industries, makes him a valuable addition to the board, particularly in his critical role as Audit Committee chair. This move follows recent board changes, indicating a strategic effort to enhance the board's expertise and composition.